We set those targets, and I am not suggesting for a minute that they are not important, but when we look at the number of people treated on both those pathways, we can see a significant increase—more patients were treated on the 62-day and 31-day pathways in the latest quarter compared with the previous quarter, and in the latest quarter compared with the same time last year, and with the last full quarter before the Covid pandemic.